InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Chaaban Bahige B.. Director active across 1 company, notably CEN Biotech INC. Aggregated, 2 disclosures have been recorded. History available since 2 April 2021. The latest transaction was disclosed on 2 April 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations